March 3, 2026 – B. Braun OEM Division introduced on March 3 that they’ve modified their identify to B. Braun Pharma & MedTech Associate. The medical gadget contract producer adopted this identify to mirror a renewed deal with key clients and strengthen its collaborative enterprise mannequin.
The group will proceed to mix shared experience, innovation and international attain to assist pharmaceutical and medical expertise corporations develop trusted merchandise that shield and enhance the well being of individuals around the globe. B. Braun Pharma & MedTech Associate will proceed to function as a division of B. Braun, one of many world’s largest medical gadget corporations, with operations in 64 nations.
The division has greater than 50 years of expertise supplying parts, assemblies and process kits and packages in an outsourcing capability. Most of its clients are main medical gadget and pharmaceutical corporations that depend on B. Braun’s greater than 5,000 registered merchandise, together with its technical experience and manufacturing capabilities, to broaden their capability and produce high-quality units to market rapidly and successfully.
The brand new identify creates a singular international id for this international staff and underlines the distinctive worth of B. Braun’s worldwide assets to work carefully with their multinational buyer base, wherever they’re positioned.
The B. Braun Pharma & MedTech Associate division absolutely embraces the B. Braun tradition of “Sharing Experience,” mentioned Brian Boschetti, Vice President of B. Braun Pharma & MedTech Associate. “We function in a cooperative ambiance based mostly on sustainability, accountability, effectivity and belief. We’re greater than a contract producer; we’re a strategic companion offering deep experience and customizable options to the markets the place our clients are in search of preferrred options.”
The brand new division was launched to the market final month throughout MD&M West.
Learn extra concerning the press launch right here.